SCHEMBL9938376

SCHEMBL9938376

NC(=O)CN1C=CCc2ccccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.38
MITF O75030 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 5/20 0.36
HPGD P15428 2/20 0.36
ALDH1A1 P00352 5/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 2/20 0.35
MAPT P10636 5/20 0.35
MEN1 O00255 4/20 0.35
KDM4E B2RXH2 2/20 0.35
CYP3A4 P08684 1/20 0.35
PABPC1 P11940 1/20 0.35
BLM P54132 1/20 0.35
POLB P06746 1/20 0.35
THRB P10828 1/20 0.35
S100A4 P26447 1/20 0.35
BRCA1 P38398 1/20 0.35
RECQL P46063 1/20 0.35
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3729599 0.85 POLB (0.40) NPC1MITFRAB9AKMT2AALDH1A1
SCHEMBL5668159 0.83 MEN1 (0.37) NPC1MITFRAB9AKMT2AALDH1A1
SCHEMBL10760096 0.78 NPC1 (0.36) NPC1MITFRAB9AKMT2AALDH1A1
SCHEMBL2734403 0.75 NPC1 (0.37) NPC1MITFRAB9AKMT2AHPGD
SCHEMBL3373922 0.75 MEN1 (0.35) NPC1MITFRAB9AKMT2AALDH1A1
SCHEMBL3266678 0.75 MEN1 (0.41) NPC1MITFRAB9AKMT2AHPGD
SCHEMBL3714616 0.74 ALDH1A1 (0.39) NPC1MITFRAB9AKMT2AHPGD
SCHEMBL6053048 0.73 ACKR3 (0.35) NPC1RAB9AKMT2AALDH1A1GAA
Bromide SCHEMBL1169843 0.73 POLB (0.33) NPC1MITFRAB9AKMT2AHPGD
SCHEMBL8448450 0.73 HTR2A (0.40) KMT2AALDH1A1MAPTMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651403-A2 USE OF LP-PLA2 INHIBITORS IN THE TREATMENT AND PREVENTION OF EYE DISEASES Glaxo Group Limited (GB) 2013-10-23 EP claimed
WO-2012080497-A2 METHODS OF TREATMENT AND PREVENTION OF EYE DISEASES GLAXO GROUP LIMITED (GB) 2012-06-21 WO claimed
EP-0233800-B1 Imidazo[1,2-a]quinoline derivatives, their preparation and therapeutical use thereof SYNTHELABO (FR) 1990-02-28 EP disclosed
EP-0233800-A1 Imidazo[1,2-a]quinoline derivatives, their preparation and therapeutical use thereof SYNTHELABO (FR) 1987-08-26 EP disclosed